Oligodendroglioma Overview

Save information for later
Sign Up

Learn About Oligodendroglioma

View Main Condition: Brain Tumor

What is the definition of Oligodendroglioma?
Oligodendroglioma is a type of brain tumor that develops from oligodendrocytes, which are specialized cells that protect neurons (nerve cells). Oligodendroglioma can occur in the brain and spinal cord.  Oligodendrogliomas are also classified as either Grade 2 or Grade 3. Grade 2 oligodendrogliomas do not spread as aggressively as Grade 3 and are less likely to cause severe symptoms. 
What are the causes of Oligodendroglioma?
The cause of oligodendrogliomas is still unknown. However, oligodendrogliomas generally tend to be more common in adults than children. Men are also more likely to develop oligodendrogliomas than women.
What are the symptoms of Oligodendroglioma?
Symptoms for oligodendroglioma primarily depend on the size and location of the tumor. Common symptoms include seizures, headaches, short-term memory issues, personality changes, and weakness on one side of the body.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Oligodendroglioma?
Treatment for oligodendroglioma may include surgery, radiation therapy, and/or chemotherapy. Surgery to remove the tumor is generally the first step in treating oligodendroglioma. Depending on the tumor's location, surgery may be able to entirely remove smaller oligodendrogliomas. However, if a tumor is located near a sensitive area in the brain, surgery may not be possible at all. Radiation therapy often follows surgery for the treatment of oligodendrogliomas. Radiation therapy involves the use of high-energy beams, including X-rays or protons, to destroy tumor cells. Chemotherapy involves the use of drugs, either taken orally or injected through a vein, to kill tumor cells. Chemotherapy is often used in combination with radiation therapy.
Who are the top Oligodendroglioma Local Doctors?
Advanced in Oligodendroglioma
Dr. Roberto E. Turnbull
Internal Medicine
Advanced in Oligodendroglioma
Dr. Roberto E. Turnbull
Internal Medicine
1177 S 6th St, Suite F, 
Indiana, PA 
 (1.5 mi)
724-349-9690
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Roberto Turnbull is an Internal Medicine provider in Indiana, Pennsylvania. Dr. Turnbull and is rated as an Advanced provider by MediFind in the treatment of Oligodendroglioma. His top areas of expertise are Oligodendroglioma, Pediatric Low-Grade Glioma (pLGG), Sitosterolemia, and High Cholesterol.

Experienced in Oligodendroglioma
Dr. Gopala A. Ramineni
Hematology Oncology | Oncology | Hematology
Experienced in Oligodendroglioma
Dr. Gopala A. Ramineni
Hematology Oncology | Oncology | Hematology

Oncology Hematology Association Inc

850 Hospital Rd, Suite 1300, 
Indiana, PA 
 (0.9 mi)
724-349-9444
Languages Spoken:
English
See accepted insurances

Gopala Ramineni is a Hematologist Oncology specialist and an Oncologist in Indiana, Pennsylvania. Dr. Ramineni and is rated as an Experienced provider by MediFind in the treatment of Oligodendroglioma. Their top areas of expertise are Familial Colorectal Cancer, Lynch Syndrome, Colorectal Cancer, and Appendix Cancer.

 
 
 
 
Learn about our expert tiers
Learn More
Experienced in Oligodendroglioma
Dr. Shiva R. Mukkamalla
Hematology | Oncology
Experienced in Oligodendroglioma
Dr. Shiva R. Mukkamalla
Hematology | Oncology

Oncology Hematology Association Inc

850 Hospital Rd, Suite 1300, 
Indiana, PA 
 (0.9 mi)
724-349-9444
Experience:
16+ years
Languages Spoken:
English, Arabic, Cantonese, Hindi

Shiva Mukkamalla is a Hematologist and an Oncologist in Indiana, Pennsylvania. Dr. Mukkamalla has been practicing medicine for over 16 years and is rated as an Experienced provider by MediFind in the treatment of Oligodendroglioma. Their top areas of expertise are Colorectal Cancer, Idiopathic Neutropenia, Familial Colorectal Cancer, and Lynch Syndrome.

View All Doctors
What is the outlook (prognosis) for Oligodendroglioma?
The prognosis for oligodendroglioma is very good with current treatments. When the tumor can be removed, survival rates are over 90%. If the tumor can not be removed but radiation therapy is used, survival rates are between 80-90%.
How do I prevent Oligodendroglioma?
There is no known way to prevent oligodendrogliomas. However, if you develop any symptoms common to oligodendroglioma, it is recommended to make an appointment with your doctor to be properly diagnosed.
What are the latest Oligodendroglioma Clinical Trials?
A Pilot Study of Safety, Tolerability, and Immunological Effects of SurVaxM in Pediatric Patients With Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma
A Pilot Study of Safety, Tolerability, and Immunological Effects of SurVaxM in Pediatric Patients With Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma
Who is this study for: Pediatric patients with progressive or relapsed medulloblastoma, high grade glioma, ependymoma and newly diagnosed diffuse intrinsic pontine glioma
Enrollment Status: Recruiting
Publish Date: April 15, 2025
Intervention Type: Biological
Study Drug: SurVaxM
Study Phase: Phase 1

Summary: Patients will receive a vaccine called SurVaxM on this study. While vaccines are usually thought of as ways to prevent diseases, vaccines can also be used to treat cancer. SurVaxM is designed to tell the body's immune system to look for tumor cells that express a protein called survivin and destroy them. The survivin protein can be found on up to 95% of glioblastomas and other types of cancer but ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Efficacy of the Intrathecal Injection of Active Allogeneic Natural Killer Cells in Patients With High-grade Gliomas; A Multi-center Phase II Clinical Trial
Efficacy of the Intrathecal Injection of Active Allogeneic Natural Killer Cells in Patients With High-grade Gliomas; A Multi-center Phase II Clinical Trial
Enrollment Status: Recruiting
Publish Date: April 09, 2025
Intervention Type: Biological
Study Phase: Phase 2

Summary: Gliomas are the most common malignant brain tumors, which are often associated with high-grade tumors characterized by an inferior prognosis and low patient survival rates in both children and adults. Surgical removal and tumor resection are the primary treatment approaches for gliomas. In such cases, whole-brain radiation therapy is also employed as a therapeutic option, which itself has signific...

View All Clinical Trials
What are some Advocacy Organizations?
keep-punching-brain-cancer

Keep Punching supports patients, healthcare providers, and researchers in their fight to prevent and eradicate brain cancer and minimize treatment-related side effects that may adversely impact function and comfort.